Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Vaccine Compensation Bill Could Open Door To Compromise With Frist

Executive Summary

Vaccine Injury Compensation Program reform legislation that includes a compromise on liability provisions is possible, Rep. Dan Burton (R-Ind.) said

You may also be interested in...



FDA “Rapid-Action” Team, Pre-Emption Included In GOP Bioterror Bill

The Senate leadership's biodefense bill for 2005 would direct FDA to create a special compliance unit to help prevent shortages of vaccines

FDA “Rapid-Action” Team, Pre-Emption Included In GOP Bioterror Bill

The Senate leadership's biodefense bill for 2005 would direct FDA to create a special compliance unit to help prevent shortages of vaccines

Rep. Burton gets subcommittee chair

Former House Government Reform Committee Chair Dan Burton (R-Ind.) named to oversee newly created Subcommittee on Wellness & Human Rights. Subcommittee will address issues concerning public health policy, human rights and family health - providing Burton with a platform to continue his investigation of vaccine safety (1"The Pink Sheet" Dec. 16, 2002, p. 18)...
UsernamePublicRestriction

Register

PS041483

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel